Specifically, would you consider either neoadjuvant or adjuvant immunotherapy in this setting, or only after recurrence?
New comment by Medical Oncologist at Cancer Center Overlook Hospital ( February 28, 2023)
You pointed out the major limitation of the ATOMIC study being 6 months of FOLFOX. It will be interesting to see this data and how many patients actually received 6 months of ...